5-177994296-C-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS1

The NM_006261.5(PROP1):​c.152G>T​(p.Gly51Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000621 in 1,611,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G51A) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000059 ( 0 hom. )

Consequence

PROP1
NM_006261.5 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -0.859

Publications

7 publications found
Variant links:
Genes affected
PROP1 (HGNC:9455): (PROP paired-like homeobox 1) This gene encodes a paired-like homeodomain transcription factor in the developing pituitary gland. Expression occurs prior to and is required for expression of pou domain transcription factor 1, which is responsible for pituitary development and hormone expression. Mutations in this gene have been associated with combined pituitary hormone deficiency-2 as well as deficiencies in luteinizing hormone, follicle-stimulating hormone, growth hormone, prolactin, and thyroid-stimulating hormone. [provided by RefSeq, Sep 2011]
PROP1 Gene-Disease associations (from GenCC):
  • pituitary hormone deficiency, combined, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypothyroidism due to deficient transcription factors involved in pituitary development or function
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • panhypopituitarism
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a chain Homeobox protein prophet of Pit-1 (size 225) in uniprot entity PROP1_HUMAN there are 37 pathogenic changes around while only 8 benign (82%) in NM_006261.5
BP4
Computational evidence support a benign effect (MetaRNN=0.009972423).
BP6
Variant 5-177994296-C-A is Benign according to our data. Variant chr5-177994296-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 742937. Variant chr5-177994296-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 742937.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000092 (14/152232) while in subpopulation EAS AF = 0.00174 (9/5166). AF 95% confidence interval is 0.000909. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PROP1NM_006261.5 linkc.152G>T p.Gly51Val missense_variant Exon 2 of 3 ENST00000308304.2 NP_006252.4 O75360A0A0G2JQ02

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PROP1ENST00000308304.2 linkc.152G>T p.Gly51Val missense_variant Exon 2 of 3 1 NM_006261.5 ENSP00000311290.2 O75360

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152114
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000222
AC:
54
AN:
243052
AF XY:
0.000227
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00215
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000739
Gnomad OTH exome
AF:
0.000505
GnomAD4 exome
AF:
0.0000589
AC:
86
AN:
1459246
Hom.:
0
Cov.:
32
AF XY:
0.0000565
AC XY:
41
AN XY:
725598
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33442
American (AMR)
AF:
0.0000451
AC:
2
AN:
44350
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26044
East Asian (EAS)
AF:
0.00121
AC:
48
AN:
39616
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86096
European-Finnish (FIN)
AF:
0.0000376
AC:
2
AN:
53260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000234
AC:
26
AN:
1110404
Other (OTH)
AF:
0.0000830
AC:
5
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152232
Hom.:
0
Cov.:
31
AF XY:
0.0000806
AC XY:
6
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41540
American (AMR)
AF:
0.00
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000877
Hom.:
13
ExAC
AF:
0.000223
AC:
27

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 17, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 36268624, 32319661) -

not specified Uncertain:1
May 13, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PROP1 c.152G>T (p.Gly51Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.2e-05 in 1611478 control chromosomes, predominantly at a frequency of 0.0013 within the East Asian subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in PROP1 causing Combined Pituitary Hormone Deficiency (6.2e-05 vs 0.0041), allowing no conclusion about variant significance. c.152G>T has been reported in the literature in individuals affected with Congenital hypothyroidism (Wang_2020). This report, however, does not provide unequivocal conclusions about association of the variant with Combined Pituitary Hormone Deficiency. Co-occurrence with other pathogenic variant has been reported (a 400 bp deletion of ANOS1), providing supporting evidence for a benign role (Dwyer_2023). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36268624, 32319661). ClinVar contains an entry for this variant (Variation ID: 742937). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Pituitary hormone deficiency, combined, 2 Uncertain:1
Jan 24, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
0.011
DANN
Benign
0.16
DEOGEN2
Benign
0.088
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.00089
N
LIST_S2
Benign
0.23
T
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
-1.2
N
PhyloP100
-0.86
PrimateAI
Benign
0.47
T
PROVEAN
Benign
1.2
N
REVEL
Benign
0.17
Sift
Benign
0.58
T
Sift4G
Benign
0.20
T
Polyphen
0.0
B
Vest4
0.12
MutPred
0.32
Loss of methylation at R53 (P = 0.0557);
MVP
0.63
MPC
0.12
ClinPred
0.0065
T
GERP RS
-4.4
Varity_R
0.026
gMVP
0.52
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2233783; hg19: chr5-177421297; API